Skip to main content
  • 124 Accesses

Auszug

Autoimmunität zählt zu den interessantesten Phänomenen, und das Wissen auf diesem Gebiet der Autoimmunerkrankungen hat in den letzten Jahren erhebliche Fortschritte gemacht. Aufgrund der Komplexität der Befunde muss von einer multifaktoriellen Genese ausgegangen werden, bei der neben genetischen Faktoren, zu denen HLA-Moleküle zählen, Hormone, Umwelteinflüsse, Chemikalien und Infektionen von Bedeutung sind. Charakterisiert werden können Autoimmunerkrankungen oftmals durch humorale oder zelluläre Immunreaktionen gegen körpereigene Gewebe. Zu ihrer Manifestation müssen verschiedene Faktoren zusammentreffen. Systemische Autoimmunerkrankungen sind oft schwer und lebensbedrohlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alarcon-Segovia D Villarreal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear natobodies. Excerpta Medica, Amsterdam, pp 33–40

    Google Scholar 

  • Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. (Part II). N Engl J Med 292: 403–407

    Article  PubMed  CAS  Google Scholar 

  • Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324: 150–154

    Article  Google Scholar 

  • Carneiro JR, Sato EI (1999) Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol 26: 1275–1279

    PubMed  CAS  Google Scholar 

  • Chan TM, Li FK, Tang CS et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343: 1156–1162

    Article  PubMed  CAS  Google Scholar 

  • Dajani AS, Taubert KA, Takahashi M et al. (1994) Guidelines for the long term management of patients with Kawasaki disease. Circulation 89: 916–922

    PubMed  CAS  Google Scholar 

  • Dalakas MC, Lila I, Dambrosia JM et al. (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993–2000

    Article  PubMed  CAS  Google Scholar 

  • Fu LW, Yang LY, Chen WP, Lin CY (1998) Clinical efficacy of cyclosporin A (Neoral) in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 37: 217–221

    Article  PubMed  CAS  Google Scholar 

  • Gaipl US, Kuhn A, Sheriff A et al. (2006) Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9: 173–187

    PubMed  CAS  Google Scholar 

  • Huber A, Birdi N, McLAine P, Klassen TP, Pothos M (2001) A randomized placebo controlled trial of prednisone in Henoch-Schoenlein purpura. Arthritis Rheum 44 (Suppl): S171

    Google Scholar 

  • Kato H, Hara T, Inoue O, Sato N, Akagi T, Sugimura T (1993) Current issues in Kawasaki disease. Acta Paediatr Jpn 35: 464–471

    PubMed  CAS  Google Scholar 

  • Lehman IJA, Sherry DD, Wagner-Weiner L, McCurdy DK, Emery HM, Magilavy DB, Kovalesky A (1988) Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediat 114: 1055–1060

    Article  Google Scholar 

  • Medsger IA (1991) Treatment of systemic sclerosis. Ann Rheum Dis 50: 877–886

    PubMed  Google Scholar 

  • Miller LC, Sisson A, Irucker B et al. (1992) Methotrexate treatment of recalcitrant childhood dermatomyositis. Arthritis Rheum 35: 1143–1149

    Article  PubMed  CAS  Google Scholar 

  • Prokunina L, Alarcon-Riquelme M (2004) The genetic basis of systemic lupus erythematosus — knowledge of today and thoughts for tomorrow. Hum Mol Genet 13: R143–148

    Article  PubMed  CAS  Google Scholar 

  • Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16: 513–521

    Article  PubMed  CAS  Google Scholar 

  • Uziel Y, Feldman BM. Krafchik BR, Yeung RS, Laxer RM (2000) Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 136: 91–95

    Article  PubMed  CAS  Google Scholar 

  • Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G et al. (1993) Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36: 340–347

    Article  PubMed  CAS  Google Scholar 

  • Wulffraat NM, Sanders LA, Kuis W (2000) Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2: 316–323

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Horneff, G., Wahn, V. (2007). Autoimmunerkrankungen. In: Reinhardt, D. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71899-4_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71899-4_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71898-7

  • Online ISBN: 978-3-540-71899-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics